SCHEMBL3897907

SCHEMBL3897907

O=C(O)CNC(=O)c1ccccc1[N+](=O)[O-]

nearest known ligand 0.66

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CTSD P07339 1/20 0.66
ALDH1A1 P00352 2/20 0.65
HTT P42858 4/20 0.58
HPGD P15428 2/20 0.58
MEN1 O00255 3/20 0.57
KMT2A Q03164 3/20 0.57
CYP1A2 P05177 1/20 0.54
CYP3A4 P08684 1/20 0.54
CYP2D6 P10635 1/20 0.54
CYP2C9 P11712 1/20 0.54
CYP2C19 P33261 1/20 0.54
LMNA P02545 2/20 0.53
TDP1 Q9NUW8 2/20 0.52
GAA P10253 2/20 0.52
KDM4E B2RXH2 1/20 0.52
MAPT P10636 1/20 0.52
ALPL P05186 1/20 0.52
NCOA1 Q15788 1/20 0.52
SMN1; SMN2 Q16637 1/20 0.52
NCOA3 Q9Y6Q9 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12311979 0.88 CRHBP (0.54) CTSDALDH1A1HTTHPGDMEN1
SCHEMBL10602289 0.87 CTSD (0.70) CTSDALDH1A1HTTHPGDMEN1
SCHEMBL27600331 0.86 CTSD (0.49) CTSDALDH1A1HTTHPGDMEN1
SCHEMBL12894737 0.86 CTSD (0.60) CTSDALDH1A1HTTHPGDMEN1
SCHEMBL1206956 0.86 CTSD (0.64) CTSDALDH1A1HTTHPGDMEN1
SCHEMBL15630987 0.85 TSHR (0.63) ALDH1A1HTTHPGDMEN1KMT2A
SCHEMBL9268117 0.83 HPGD (0.62) CTSDALDH1A1HTTHPGDMEN1
SCHEMBL1206625 0.83 CTSD (0.60) CTSDALDH1A1HTTHPGDMEN1
SCHEMBL30236290 0.83 KMT2A (0.75) CTSDALDH1A1HTTHPGDMEN1
SCHEMBL19246188 0.83 KMT2A (0.75) CTSDALDH1A1HTTHPGDMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-102070433-A Preparation method for aryl acetic acid derivative GUILIN NORMAL COLLEGE 2011-05-25 CN claimed
CN-112899264-B Normal-temperature aerobic treatment method for perishable garbage 杭州楠大环保科技有限公司 2022-05-24 CN disclosed
CN-112899264-A Normal-temperature aerobic treatment method for perishable garbage 杭州楠大环保科技有限公司 2021-06-04 CN disclosed
CN-102070433-B Preparation method for aryl acetic acid derivative GUILIN NORMAL COLLEGE 2013-03-27 CN disclosed
CN-102070433-A Preparation method for aryl acetic acid derivative GUILIN NORMAL COLLEGE 2011-05-25 CN disclosed
EP-1366063-B1 INHIBITORS OF LYN-ASSOCIATED SIGNAL TRANSDUCTION (LAST) AND THE USE THEREOF IN THE TREATMENT OF PROSTATE CANCER CHILDRENS MEDICAL CENTER (US) 2009-02-18 EP disclosed
US-20070249847-A1 Method for Producing Acetamidopyrrolidine Derivatives and Intermediate Compounds Thereof TEIJIN PHARMA LIMITED (JP) 2007-10-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070249847-A1 Method for Producing Acetamidopyrrolidine Derivatives and Intermediate Compounds Thereof HDHD5, CBR3, ADH5 CTSD 2954/4885ALDH1A1 139/4885HTT 1503/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.